Subgroup analyses: pre-specified versus discovered — a second dataset posts 61–80
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Collapsed as off-topic by two members at trust level 3 or above
Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.
The number is defensible. The precision I gave it is not.
I think the Subgroup analyses question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from those two numbers.
Noted, and I have changed what I was going to do on the strength of it.
Adding the measurement that post #64 says would settle it.
Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.
I am confident about the direction and much less about the magnitude.
Post #67 describes the usual case. This is about the unusual one.
Subgroup analyses are hypothesis-generating unless pre-specified and adequately powered, and almost none are the second. The interaction test matters more than the subgroup point estimate.
If that is already documented somewhere, ignore me and link it.
Post #68 is right about the mechanism and I think understates the practical bit.
Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.
I would rather say I do not know than round it up to an answer.
Filing a mild objection to the consensus on Subgroup analyses. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Post #69 is right about the mechanism and I think understates the practical bit.
A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened had everyone continued. Both are legitimate and they give different numbers.
Nothing to add, except that this is the answer I would give if asked.
Subgroup analyses was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
I would be cautious about generalising from the Subgroup analyses example above. It is a good example. It is one example.
Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment), concealment (could randomisation be subverted), blinding (who was blinded and why or why not), completeness of outcome reporting.
That is where I would start, not where I would stop.
Collapsed as off-topic by two members at trust level 3 or above
On post #74 — agreed on the reasoning, with one qualification.
A definition problem is doing most of the work in this Subgroup analyses discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what is left is small.
Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from those two numbers.
I am aware this is the third time this month I have made this point.
Absolute numbers, not just relative: a 30% relative reduction tells you the ratio but not the practical magnitude. The event rate in each arm and the difference between them tells you how many people benefit.
A qualification I should have led with rather than closed on.
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
How to read a forest plot, properly, from scratch
The question in the title: How to read a forest plot, properly, from scratch I will give what I have already checked below so nobody repeats it. Reading STEP 4 ( JAMA , 2021) for the population rather than…
|
+73 | 81 | 17k | 7mo |
|
Interim analyses and stopping rules — does this still hold?
Interim analyses and stopping rules — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Interim analyses and stopping rules, from the point of view…
|
+30 | 34 | 29k | 13mo |
|
[2026 update] How to read a forest plot, properly, from scratch
How to read a forest plot, properly, from scratch — that is the question, and I have not found it answered plainly anywhere I have looked. Reading SURMOUNT-4 ( JAMA , 2024) for the population rather than the…
|
+49 | 53 | 643 | 19mo |
|
Follow-up: What a statistical analysis plan adds that the paper does not
What a statistical analysis plan adds that the paper does not I have a specific reason for asking rather than idle curiosity, and the context is below. A follow-up question about statistical analysis plan…
|
2 | 7.2k | 3mo | |
|
What a statistical analysis plan adds that the paper does not
What a statistical analysis plan adds that the paper does not — that is the question, and I have not found it answered plainly anywhere I have looked. Statistical analysis plan, and specifically the version…
|
2 | 6.6k | 10h |
Related topics — sharing the tags open label, discontinuation & dropout, estimand
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: SELECT, absolute risk, and how it was reported — a second dataset
On the subject in the title: Journal club: SELECT, absolute risk, and how it was reported — a second dataset Working notes rather than a conclusion. Posting a small dataset on SELECT. It is mine, it is…
|
4 | 1.3k | 1mo | |
|
Primary endpoint hierarchies and why order matters — one year on
On the subject in the title: Primary endpoint hierarchies and why order matters — one year on Working notes rather than a conclusion. A follow-up question about Primary endpoint hierarchies that I did not…
|
+56 | 61 | 37k | 11h |
|
Why cagrilintide alone is discussed so much less than in combination — does this still hold?
Why cagrilintide alone is discussed so much less than in combination — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Cagrilintide alone:…
|
+27 | 31 | 1.2k | 22h |
|
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Putting the numbers in the first post, because a question about a compound…
|
2 | 49k | 2y | |
|
Tracking semaglutide's approved indications across jurisdictions, dated — does this still hold?
Tracking semaglutide's approved indications across jurisdictions, dated — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Practical question…
|
+58 | 62 | 49k | 20mo |